Hepatocellular Carcinoma Registry for Turkey (3K Trial)
Completed
- Conditions
- Hepatocellular Carcinoma
- Registration Number
- NCT01473121
- Lead Sponsor
- Bayer
- Brief Summary
This registry study is national, multi-center, prospective study without any interventions to the treatment strategies and/or decisions of the investigators. It is designed in order to determine the general profile of HCC patients in Turkey. Socio-demographic characteristics, family history, medical history and treatment pattern of HCC patients will be evaluated.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
- To be diagnosed with hepatocellular carcinoma in last 3 months
- To be older than 18 years old
- To sign informed consent form (ICF)
Exclusion Criteria
- Patients that does not sign or withdraw informed consent form.
- According to investigator's opinion; existence of any situation/condition that will significantly complicate patient follow up.
- Currently or previously taking part in 3K observational study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Descriptive analysis of HCC risk factors Baseline i.e. smoking and alcohol consumption status; family history for hepatitis, HCC, and other malignancies; history of hepatic disease and blood transfusion; concomitant diseases; treatments applied
Descriptive analysis of clinical profile of newly diagnosed HCC patients Baseline
- Secondary Outcome Measures
Name Time Method Number of participants with underlying liver disease and family history Baseline Treatment options as applied by doctors to HCC patients Up to approximately 5 years Overall survival time since diagnosis Up to approximately 5 years Number of participants with adverse events Up to approximately 5 years Descriptive analysis of demographic characteristics of HCC patients Baseline Descriptive analysis of clinical characteristics of HCC patients Up to approximately 5 years Descriptive analysis of tumor properties Up to approximately 5 years